-

Hims & Hers Partners with REVOLVE to Help More Consumers Access High Quality, Personalized Health and Wellness Solutions

Partnership will provide a wide variety of Hims & Hers products on REVOLVE.com

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, today announced a partnership with REVOLVE (NYSE: RVLV), a premium lifestyle fashion retailer and go-to online source for discovery and inspiration with Millennial and Generation Z consumers. REVOLVE is adding a diverse range of health and wellness solutions from Hims & Hers to its site, REVOLVE.com.

“Both Hims & Hers and REVOLVE are redefining industries and leveraging our brands to identify closely with the next generation of consumers,” said Melissa Baird, Chief Operating Officer of Hims & Hers. “Collaborating with a brand that understands the intricacies of taking a unique approach and has the ability to communicate authentically is critical as we look to bring more personalized health and wellness solutions to Millennial and Generation Z consumers. We are thrilled to be able to offer a variety of our products to REVOLVE’s deeply engaged consumer audience on what they consider to be a trusted, beloved and dynamic platform.”

The Hims & Hers products that are now available on REVOLVE.com include items for skincare, hair care and growth, sleep supplements, and sexual health, and are both affordable and thoughtfully designed.

“We are very excited to announce our partnership with Hims & Hers and share their vision of democratizing access to health and wellness. REVOLVE is a trusted, premium lifestyle brand, and a go-to online source for discovery and inspiration and we want to offer our customers the ability to shop affordable and quality health and wellness solutions. Through providing a wide variety of Hims & Hers products on REVOLVE we are expanding into new categories and further diversifying REVOLVE’s dynamic platform,” said REVOLVE Chief Brand Officer Raissa Gerona.

Hims & Hers recently served as REVOLVE’s exclusive wellness partner during REVOLVE’s New York Fashion Week events as well. For more information please visit www.forhims.com, www.forhers.com, or www.revolve.com.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

About Revolve Group, Inc.

Revolve Group, Inc. (RVLV) is the next-generation fashion retailer for Millennial and Generation Z consumers. As a trusted, premium lifestyle brand, and a go-to online source for discovery and inspiration, we deliver an engaging customer experience from a vast yet curated offering of apparel, footwear, accessories, and beauty styles. Our dynamic platform connects a deeply engaged community of millions of consumers, thousands of global fashion influencers, and hundreds of emerging, established, and owned brands.

We were founded in 2003 by our co-CEOs, Michael Mente and Mike Karanikolas. We sell merchandise through two complementary segments, REVOLVE and FORWARD, that leverage one platform. Through REVOLVE, we offer an assortment of premium apparel and footwear, accessories, and beauty products from emerging established and owned brands. Through FORWARD, we offer a highly curated assortment of iconic and emerging luxury brands. For more information, visit www.revolve.com and @REVOLVE.

Contacts

Linda O'Connor
Hims & Hers
press@forhims.com

REVOLVE press team
REVOLVE@walkerdrawas.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers partners with REVOLVE to offer diverse range of health and wellness solutions on its site, REVOLVE.com.
Release Versions

Contacts

Linda O'Connor
Hims & Hers
press@forhims.com

REVOLVE press team
REVOLVE@walkerdrawas.com

More News From Hims & Hers Health, Inc.

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering, demonstrating the company’s ability to meet the unique needs of each global market it serves while continuing its international expansion efforts. Personalized treatment plans are available starting at $149 CAD/month, making...

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to treatment. For eligible customers, personalised treatment plans are available starting at $149/month CAD. GLP-1 treatments have transformed obesity and metabolic health, with...

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering of $350 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced of...
Back to Newsroom